|
HS Code |
226861 |
| Chemical Name | 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate |
| Common Name | Fenspiride Fumarate |
| Molecular Formula | C25H35NO3·C4H4O4 |
| Molecular Weight | 531.7 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water and alcohol |
| Melting Point | Approx. 186-188°C |
| Cas Number | 5053-06-5 |
| Storage Condition | Store in a cool, dry place, protected from light |
| Usage | Pharmaceutical intermediate; expectorant and anti-inflammatory agent |
As an accredited 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle labeled “2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate, 25g,” tamper-evident seal, hazard pictograms. |
| Shipping | The chemical **2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate** should be shipped in tightly sealed, chemical-resistant containers, labeled according to GHS guidelines. It must be protected from light, moisture, and extreme temperatures during transit, and accompanied by a Safety Data Sheet (SDS) as per relevant regulations. |
| Storage | Store **2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate** in a tightly sealed container, away from moisture, light, and heat sources. Keep in a cool, dry, well-ventilated area, and segregate from incompatible materials such as oxidizing agents. Ensure proper labeling and restrict access to authorized personnel. Follow all relevant safety and handling guidelines. |
Applications of 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate in Industrial ManufacturingAs a specialized manufacturer, we support industrial partners with 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate produced under dedicated quality management systems. This advanced intermediate plays a recognized role in regulated downstream applications, reflected in the mature portfolio of our long-term global customers. Below, we outline the core industrial sectors that integrate this material in their continuous or batch processes and specify technical details for each application scenario. 1. Pharmaceutical Intermediate for Central Nervous System (CNS) Active CompoundsMajor pharmaceutical companies utilize 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate as a key intermediate in multi-step syntheses of CNS-targeted APIs. Formulation teams introduce this raw material during the late intermediate stage, ensuring consistency and traceability under strict pharmaceutical guidelines. Production requires complete GMP records and is audited for individual impurity profiles. The substance undergoes chemical conversion, ultimately yielding active ingredients for regulated neurologic therapies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Active Ingredient in Veterinary Drug ManufacturingLeading veterinary pharmaceutical firms utilize this raw material as a controlled chemical precursor in the synthesis of psychoactive veterinary agents. QC laboratories validate the integrity of each batch in accordance with international animal health standards. Formulation scientists combine it with other precise reactants in closed-system reactors, maintaining strict documentation for regulatory inspections. Final veterinary medications address species-specific CNS disorders under licensed conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate in Custom Fine Chemical Synthesis for Contract Research and DevelopmentContract research organizations (CROs) and custom synthesis manufacturers rely on this fumarate salt as a specialty building block for targeted structure-activity relationship (SAR) programs and pilot plant scale-up. Laboratories often demand on-specification material supplied with comprehensive analytical documentation. The compound enters iterative synthesis workflows, enabling rapid evaluation of new CNS-active analogs or patent-protected chemical entities in exploratory medicinal chemistry. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Ingredient in High-Purity Reagents for Diagnostic Assay Kit ProductionProducers of specialized diagnostic reagents use this compound to create high-purity calibration standards and molecular markers for CNS drug screening kits. The raw material undergoes controlled micronization or recrystallization and is incorporated early in reagent batch assembly. Each lot must meet strict analytical specifications, including residual solvent controls and trace impurity profiling, to ensure compatibility with downstream assay chemistries. Finished products address clinical laboratory and research sector requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry in the manufacturing world isn’t just a game of numbers and processes. It involves years spent fine-tuning results on the shop floor, troubleshooting reactors, and witnessing how purity and structure affect the final outcome. 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate stands as a compound reflecting the patient work done across a hundred synthesis runs—a remarkable track record built on consistency and deep-rooted technical insight.
Having manufactured this molecule, our facility relies on both robust batch controls and real chemical know-how that only years of hands-on practice can offer. Each run undergoes repeated calibration using chromatography analysis, so trace levels meet stringent internal benchmarks. The knowledge does not stop at the HPLC results. It also extends to how operators set the feed rates, how solvents behave under certain temperatures, and the daily grind of cleaning vessels to prevent contamination between batches.
Lab technicians often look for narrow melting point ranges and spectral fingerprint matches; producers must deal with day-to-day variation. Our material steps out of the flask with a purity held consistently above 99.5% by rigorous process design rather than chance. NMR and IR spectra are not abstract data—they represent hours spent dialing in reaction timing, solvent selection, and drying conditions. Physical consistency in crystalline form means no surprises when handling, scaling, or formulating—valuable for anyone measuring solubility in a pilot plant or watching for batch-to-batch performance drifts.
Weight, appearance, and color are not afterthoughts; they affect every downstream operation. Batches come out as a free-flowing, off-white crystalline solid because we control temperature profiles and filtration steps, not just upstream purity. These details smooth the way for accurate dosing, reliable dispensing, and problem-free compounding when the material becomes part of a finished active or an advanced intermediate.
Experience shows which molecules endure the rough conditions of scale-up and which ones falter. This compound’s structure has proven robust in multi-step transformations common in research, development, and full-scale manufacturing. Medicinal chemists value the phenylpropyl backbone for the stability it offers under diverse conditions, and this genuine strength shows up when shifting from gram to kilogram.
Beyond stability, the inclusion of the fumarate counterion balances hydrophilicity and lipophilicity, a challenge often underestimated in laboratory catalogs. Real trials have shown how this salt improves process handling—offering better isolation, easier crystallization, and less environmental risk from residual solvents. It has played a role in synthetic routes toward APIs and advanced pharmaceutical intermediates by providing both structural rigidity and desired solubility profiles.
The difference between two chemical products rarely shows up on paper alone. What matters are the findings gathered from real worksites, long shift cycles, and QC labs late at night. Some manufacturers use quicker or cheaper reagents to accelerate throughput, but we have found this often leads to impurities that complicate downstream processing. From experience, skipping purification steps may save a day, but it creates headaches in chromatographic separation or delay during regulatory documentation.
This particular fumarate compound comes from a reaction setup designed around phase-appropriate controls. In-process monitoring isn’t sacrificed for scale. Many of our clients originally struggled with off-color batches, poor filterability, or residue that gummed up reactors when sourcing elsewhere. Switching to our material has lowered their filtration times and given predictable crystallization behavior when scaled tenfold.
Because the compound reacts cleanly in both aqueous and nonaqueous settings, process development teams gain flexibility. Our product’s manageable particle size distribution directly influences its dispersibility in solvents or carriers—attributes not easily listed in a technical data sheet but recognized by anyone blending large batches or moving through multi-step cascades. Clients’ pilot lines often report fewer stuck filters, more reliable yields, and less tolling delay due to rework or inconsistent feedstock.
Consistency isn’t granted by certificates. It results from hard-earned insight into every stage, from raw material sourcing to post-processing. Our operators keep a sharp eye on solvent volatility and handle strict metering of all reactants—not just according to procedure but informed by instinct built over years in bulk and fine chemical production. Minute changes in color or formation of fines during drying don’t escape notice.
Down the road, analytical chemists review every batch by cross-checking chromatograms and spectral data against master standards. If impurities appear above an internal alarm, even when regulatory standards would let them pass, our team stops and investigates. We take these actions not because it looks good on an audit, but because the next step in synthesis or formulation often amplifies the smallest flaw.
Longstanding dialogue between production and quality analysts has shaped the way we respond to unexpected trends. Small day-to-day deviations, whether in thermal stability or filter cake quality, become early warning signals for potential scale-up issues. These patterns, tracked and discussed over years, let us intervene early, reduce waste, and tighten each process loop—measures that deliver real value to scientists and manufacturing partners who depend on steady material output.
Supply chains have taught manufacturers difficult lessons, none more clear than during swings in demand and changing global regulations. Flexible planning, supported by a firm grip on available raw materials, ensures unbroken delivery schedules. Our compound’s production survives stress tests often, from tight deadlines to spikes in demand due to a development race. Stockpiles lose their meaning if purity drops. Every container under our control is kept within strict humidity and temperature windows to preserve specification.
Our logisticians and production schedulers meet weekly to match delivery commitments with actual shop floor output. Late shipments, which sometimes result from material unavailability elsewhere, have rarely interrupted our clients’ timelines. Others in our sector have shifted to just-in-time models and suffered from batch-to-batch variability, but we maintain reasonable inventory without compromising the chemical’s stability. These decisions come from living through disrupted projects and knowing how the smallest lapse can break a project’s momentum.
Not every chemical is straightforward to handle. Over years of production and scale-up, we have learned that controlling the final salt’s crystallization parameters means better purity and filterability. Some operators, new to this compound, try to cool too rapidly and end up with unwanted polymorphs. Solvent ratios, so easy to overlook on a process sheet, make all the difference: a small excess can lead to product oiling out, a shortage risks incomplete conversion.
The design of our equipment also reflects countless minor adjustments. Reactor agitation speeds and filtration hardware size match not just the compound but how it behaves as it comes out of solution—knowledge that comes from clogged filters and wasted hours more often than from neat decision trees. Training for new staff emphasizes responding to in-process signals early, not waiting for QC to catch errors downstream. More than one insight has been carved from a failed batch, leading to process tweaks that keep the current process smooth for both small and large-scale orders.
Being a direct producer offers visibility into technical problems that never reach spec sheets or catalogs. Conversations with development scientists have led us to modify drying cycles for even tighter moisture content tolerances, or to adjust the packing density in drums for better reconstitution later. When a purchaser faces dissolution problems or crystallization issues using the material in their process, advice comes straight from the people who have struggled and succeeded with the same problems firsthand.
We also bring a producer’s mindset to regulatory support. Full traceability of every input—along with batch records, analytical data, and stability logs—form the backbone for customs documentation or clinical trial filing. Even if not every customer asks for the granular data behind each batch, it remains there, underpinning every sale with confidence drawn from direct transparency. Years working under both local and international oversight have left us prepared for certifications, registrations, and technical questions with no bureaucratic runaround.
Catalogs and brochures tend to focus on technical points, like nominal assay values or stated melting ranges. Reality sets a higher bar. We have seen plenty of material—from resellers or competing manufacturers—fall short when moved out of R&D and into full operation. Sourcing from the originator removes the risk of repackaging contamination, relabeling uncertainty, or undocumented storage conditions. Our batches are never shuffled between intermediaries before reaching a client’s dock.
Within our own product lines, this fumarate compound demonstrates less lot-to-lot drift compared to related salts, due to both process benefits and control of raw input ratios. Some clients, after trying benzoate or hydrochloride alternatives for the same intermediate, found that crystallization and drying steps ran slower or suffered mechanical handling problems. Our own workflow, focusing on fewer but deeper quality checks, delivers a material that reacts in a cleaner, more predictable fashion. Observations from pilot projects confirm higher transformation yields and simpler purification steps when swapping in our fumarate.
A good chemical manufacturer becomes a partner in progress. A lot happens after the handshake, and most value surfaces long after the first drum leaves our site. Our team remembers requests—sometimes down to specific handler or tank preferences—and factors them into future shipments. If a customer signals a process shift or new compliance threshold, our technical liaison team acts, adjusting our own controls to stay a few steps ahead.
Regular feedback sessions with industrial clients often expose small inefficiencies unearthed only during months of continued use. One memorable case involved gradual color shifts barely visible to the human eye, later tracked to micro-changes in a raw input. This detail might have gone unnoticed in a larger, fast-moving operation, but hands-on batch review and open customer dialogue helped isolate and rectify the cause—an outcome almost impossible without the close-knit methodology built into our operation.
Standing alongside operators during a midnight run, watching the reflux column steam then settle, puts technical decisions into perspective. Minor improvements to yield, purity, and working rates rarely stem from directives or outside audits—they arise from watching, tinkering, and experimenting within the constraints of a living plant. The advances behind our best batches of 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate come straight out of these moments, where trial and hands-on correction trump abstraction.
Countless hours of maintaining, recalibrating, and adjusting the plant’s operations make claims of reliability real. Customers reach out with technical or logistical snags, and the answers we share echo the same practical, field-tested approach. From the level gauge on the storage tank to checks on packing seals during shipment, each detail aims to preserve the investment customers make in their own process by choosing our product.
The landscape for specialty intermediates never stands still. Compliance thresholds continue tightening. Downstream applications push for higher selectivity, increased throughput, or a better balance between environmental safety and performance. As a chemical manufacturer, our edge has always come from the hard work done in real time, on real production lines, answering to those whose own work depends on our reliability.
We continue improving with every campaign—adopting new monitoring tools, reviewing production logs for process drift, and staying curious about both upstream and downstream best practices. Decades in production have taught us the value of stable supply, direct answers, and process transparency. Our own experience—hard won, and shared across the whole team—shows up in the quality and dependability of every shipment. For partners in research, formulation, or full-scale manufacturing, working with our 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenyl-Propyl]-4-Methyl-Methoxybenzene Fumarate means access to a supply chain, and a support team, tested by real lab benches and working plant floors.